Department of Medical Oncology;
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital;
Chinese Academy of Medical Sciences and Peking Union Medical College;
Beijing 100021;
China;
Department of VIP Medical Services;
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital;
Chinese Academy of Medical Sciences and Peking Union Medical College;
Beijing 100021;
China;
Nanjing Geneseeq Technology Inc.;
Nanjing 210032;
China;
Cancer Hospital of Huanxing Chaoyang District Beijing;
Beijing 100021;
China;
Anlotinib; angiogenesis; HER2-negative; breast cancer; ct DNA;